Q1 Scientific, which from now on belongs to the Cambrex group (USA), offers services allied to stability studies, to biorepository, as well as to temperature-controlled storage rooms. These involve essential elements in developing clinical studies. The enterprise already had clients in Belgium and talked with them from Ireland: from now on, these relations will be able to operate locally because Q1 Scientific is establishing a unit at Villers-le-Bouillet, where 10 jobs will need to be created as quickly as possible.

The fact of becoming integrated in an existing value chain is a determining element in the decision by the company, which is also relying on Wallonia's trump cards, such as the skilled and available labour force or, additionally, the effective logistics infrastructures, to create value.

"We are delighted to establish a unit in Wallonia, from where it will be equally easy for us to serve our clients in France, Germany and the Netherlands," explains Tom Loewald, Cambrex CEO.

Franck Toussaint, Supply Chain Manager at Wallonia Export-Investment Agency: "This is also good news for the pharmaceutical enterprises that have already been established in our country and that see how the services offered in the area are developed. Reinforcing this value chain is also extremely important within the context of establishing a biologistics valley here in Wallonia.